1. Torrance GW, Feeny D, Furlong W.Visual analog scales: do they have a role in the measurement of preferences for health states?Med Decis Making. 2001;21(4):329–334.
2.
2. Mrus JM, Yi MS, Freedberg KA, et al. Utilities derived from visual analog scale scores in patients with HIV/AIDS. Med DecisMaking. 2003;23(5):414–421.
3.
3. O’Leary JF, Fairclough DL, Jankowski MK, Weeks JC. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med Decis Making. 1995;15(2):132–137.
4.
4. Elkin EB, CowenME, Cahill D, SteffelM, Kattan MW. Preference assessment method affects decision analytic recommendations: a prostate cancer treatment example. Med Decis Making. 2004;24(5): 504–510.
5.
5. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993;269(20):2650–2658.